Swanton, VT, United States of America

Brad L Barnett

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2011-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Brad L. Barnett

Introduction

Brad L. Barnett, an accomplished inventor based in Swanton, Vermont, has made significant contributions to the field of transdermal drug delivery systems. With three patents to his name, his work reflects a deep understanding of pharmaceutical technologies and innovative manufacturing processes.

Latest Patents

Among Barnett's notable inventions is his patent for a "Process for the continuous manufacture of a polyisobutylene based transdermal patch." This invention is directed towards developing a transdermal delivery device that features a backing layer, a release liner, and an adhesive layer positioned between the two. The core of this invention focuses on a method for preparing the adhesive layer, which consists of polyisobutylene combined with an active pharmaceutical ingredient. This novel approach improves the manufacturing efficiency and effectiveness of transdermal patches.

Career Highlights

Throughout his career, Brad L. Barnett has worked with reputable companies, including Mylan GmbH and Mylan Technologies, Inc. His experience within these organizations has likely enriched his expertise and facilitated his inventive pursuits in drug delivery technologies.

Collaborations

Barnett has collaborated with several professionals in his field, most notably Russell Adam Baird and Russell D. Beste. These partnerships likely contributed to the refinement and success of Barnett's innovative processes.

Conclusion

In summary, Brad L. Barnett stands out as a dedicated inventor whose contributions in the development of transdermal patches illustrate his commitment to advancing pharmaceutical technology. With his valuable patents and collaborative efforts, Barnett continues to pave the way for innovative solutions in drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…